BMY
BMY
US1101221083
Bristol-Myers Squibb Company
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
120.77B EUR
117.64B EUR
123.83B EUR
109.81B EUR
Enterprise Value
155.69B EUR
153.98B EUR
160.69B EUR
146.74B EUR
Valuation Multiples
Trailing P/E
13.02x
12.67x
17.02x
23.88x
Forward P/E
8.94x
--
--
--
Price to Sales
2.46x
2.39x
2.55x
2.97x
Price to Book
5.41x
5.27x
6.17x
5.94x
EV/Revenue
3.17x
3.13x
3.31x
3.97x
EV/EBITDA
8.23x
8.28x
8.44x
9.85x
Price to FCF (P/FCF)
14.88x
10.28x
10.4x
9.85x
EV/FCF
19.19x
13.46x
13.49x
13.16x
FCF Yield
6.72%
9.72%
9.62%
10.15%
ende